Blog

Discover how new biopsy-equivalent diagnostic solutions are replacing invasive procedures with faster, safer, and more accurate non-invasive testing methods.

Explore the shift toward label-free CTC enrichment methods. Discover how size, density, and electrical properties are improving the detection of heterogeneous cancer cells.

Explore the latest clinical studies from BloodScan Biotech. Discover how our research in biomarker analysis and AI-driven diagnostics is shaping the future of medicine.

Learn the most effective techniques for isolating intact Circulating Tumor Cells (CTCs) from blood samples, including affinity-based and size-based strategies.

Discover how liquid biopsy is revolutionizing solid tumor staging. Learn about its role in monitoring treatment response, detecting recurrence, and precision oncology.

Explore the clinical significance of genomic concordance between liquid and tissue biopsies in oncology and how they impact precision medicine.

Discover how the Labyrinth One liquid biopsy system is changing cancer diagnosis with non-invasive, high-sensitivity CTC isolation and real-time monitoring.

Discover how blood-based cancer diagnostic tools (liquid biopsies) are revolutionizing oncology, offering minimally invasive, early, and accurate detection of cancer.

Curious about what a liquid biopsy is? Learn how this breakthrough blood test is transforming cancer detection, monitoring, and precision treatment.

Explore the latest breakthroughs in Circulating Tumor Cells (CTC) isolation technology. Learn how liquid biopsies are transforming cancer diagnostics and precision medicine.

CTC enumeration counts intact tumor cells; ctDNA measures tumor DNA fragments. Here's how each tracks treatment response in oncology trials.

Can a blood test catch cancer early? Some CTC liquid biopsies can. BloodScan reports detecting circulating tumor cells in pre-invasive DCIS and early HCC.

How accurate is a CTC liquid biopsy? BloodScan reports 97% genomic concordance with matched tissue—here is what accuracy means for whole, intact CTCs.

Circulating tumor cells (CTCs) are intact cancer cells shed from tumors into the bloodstream. Learn what they are, why they matter, and how they're captured.

CTCs and ctDNA are both liquid biopsy analytes, but only CTCs preserve whole, intact cells. Here's how they differ and when each is the right choice.

CTCs offer a non-invasive way to track tumor dynamics across an oncology trial — enumeration, genomics, and functional assays from serial blood draws.

Tissue biopsy and liquid biopsy answer different clinical questions. Here is when each makes sense and where intact CTCs bridge the two approaches.